Coronavirus / COVID-19 Pandemic Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Wharf Rat who wrote (22865)	10/21/2025 12:32:20 PM
From: Sam	4 Recommendations Recommended By John Koligman Kirk © Ron Wharf Rat of 22866

A surprise bonus from COVID-19 vaccines: bolstering cancer treatment Patients who got shots of mRNA before starting a type of cancer immunotherapy lived much longer 20 Oct 2025 6:10 PM ET By Phie Jacobs The innovative messenger RNA (mRNA) vaccines that thwarted the ravages of COVID-19 may also help fight tumors in cancer patients, according to a new analysis of medical records and studies in mice. People with cancer who coincidentally received the mRNA shots before starting drugs designed to unleash the immune system against tumors lived significantly longer than those who didn’t get vaccinated, a research team announced yesterday at the European Society for Medical Oncology Congress in Berlin. Laboratory experiments by the group suggest the vaccines rev up the immune system, making even stubborn tumors more susceptible to treatment. The findings underscore the still-untapped potential of mRNA technology at a time when President Donald Trump’s administration has backed away from funding the area. “I think this data is extraordinary,” says Ryan Sullivan, an oncologist and immunologist at Massachusetts General Hospital who wasn’t involved in the new research. Although the analysis of cancer patient data was retrospective, he notes that the observed association between COVID-19 vaccination and improved survival “is very strong.” The innovative messenger RNA (mRNA) vaccines that thwarted the ravages of COVID-19 may also help fight tumors in cancer patients, according to a new analysis of medical records and studies in mice. People with cancer who coincidentally received the mRNA shots before starting drugs designed to unleash the immune system against tumors lived significantly longer than those who didn’t get vaccinated, a research team announced yesterday at the European Society for Medical Oncology Congress in Berlin. Laboratory experiments by the group suggest the vaccines rev up the immune system, making even stubborn tumors more susceptible to treatment. The findings underscore the still-untapped potential of mRNA technology at a time when President Donald Trump’s administration has backed away from funding the area. “I think this data is extraordinary,” says Ryan Sullivan, an oncologist and immunologist at Massachusetts General Hospital who wasn’t involved in the new research. Although the analysis of cancer patient data was retrospective, he notes that the observed association between COVID-19 vaccination and improved survival “is very strong.” science.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext